
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
ARK-2 CRISPR/Cas9 KO Plasmid (m) | sc-423197 | 20 µg | $397.00 |
Aurkb (ARK-2) encodes a serine/threonine kinase that functions as the catalytic core of the chromosome passenger complex, coordinating chromosome condensation, kinetochore–microtubule attachment error correction, and cytokinesis. ARK-2 activity is regulated across mitosis through phosphorylation-dependent signaling and spatial relocalization from centromeres to the spindle midzone, coupling spindle assembly checkpoint satisfaction to faithful chromosome segregation. Disruption of Aurkb perturbs chromatin dynamics and contractile ring formation, leading to aneuploidy and micronuclei, processes frequently leveraged to study genome instability. Altered AURKB signaling has been implicated in proliferative phenotypes and tumor-associated chromosomal instability, making it a common node in cell cycle and mitotic fidelity research.
ARK-2 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Aurkb gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Aurkb together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Aurkb open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish ARK-2 protein expression.
This CRISPR knockout system enables efficient generation of Aurkb-deficient cell models for investigation of ARK-2 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.